Diversifying your Cancer Immunotherapy Investments with B cell Activation Approaches
Background on Company Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B…
Author
FON Editorial is the newsroom of Family Office Networks (FON), founded in 2014 by Andrew Schneider. The editorial team reports on family offices, ultra-high-net-worth investing, private markets, philanthropy, and luxury, under the FON Editorial Standards. Story tips and corrections: editorial@familyofficenetworks.com.
Articles by FON Editorial
Member Spotlight – Bunkport Partners
Member Spotlight – Bunkport Partners Investor behavior has remained consistent for more than 100 years. Investors still overreact to bad news and underreact to good…
Investing in Precious Metals Miners Part 6 – 10 Rules for Investing in Gold Miners
Investing in Precious Metals Miners Part 6 – 10 Rules for Investing in Gold Miners Part of an ongoing discussion with Equinox Partners about…
Soligenix, Inc. – A rare disease company with multiple near-term and potentially transformational catalysts
Soligenix, Inc. – A rare disease company with multiple near-term and potentially transformational catalysts Drug development takes many years, but Soligenix has arrived in…
How Millionaires Will Ride Out the Next Portland or Sarajevo
How Millionaires Will Ride Out the Next Portland or Sarajevo Just one year ago, had you been told that downtowns around the US would…
Hemptown USA: Building the Procter and Gamble of the Cannabinoid Industry
Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG, and the…
Investing in Precious Metals Miners Part 5 – Gold Mining Appetite
Investing in Precious Metals Miners Part 5 – Gold Mining Appetite Part of an ongoing discussion with Equinox Partners about investing in precious metals…
Reprogramming the Course of Cancer and Diabetes
Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer…
Limitless Creativity The Future of Color Formulation
Come join the Family Office Networks Webinar Series Featuring CLICS. CLICS is the first digital hair color studio for stylists and pay per dispense…
How Family Offices Can Partner with Venture Firms and Corporates for Enhanced Returns
Come Join the Family Office Networks Webinar Series featuring Impact Venture Capital. Eric Ball, General Partner with Impact will lead a panel discussion that…